stata command glm Search Results


glm command in stata  (STATA Corporation)
99
STATA Corporation glm command in stata
Glm Command In Stata, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glm command in stata/product/STATA Corporation
Average 99 stars, based on 1 article reviews
glm command in stata - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
glm command in minitab  (Minitab Inc)
86
Minitab Inc glm command in minitab
Glm Command In Minitab, supplied by Minitab Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glm command in minitab/product/Minitab Inc
Average 86 stars, based on 1 article reviews
glm command in minitab - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
glm command  (STATA Corporation)
99
STATA Corporation glm command
Glm Command, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glm command/product/STATA Corporation
Average 99 stars, based on 1 article reviews
glm command - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
fmm glm  (STATA Corporation)
99
STATA Corporation fmm glm
Fmm Glm, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fmm glm/product/STATA Corporation
Average 99 stars, based on 1 article reviews
fmm glm - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
command glm  (STATA Corporation)
99
STATA Corporation command glm
Command Glm, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/command glm/product/STATA Corporation
Average 99 stars, based on 1 article reviews
command glm - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
glm  (STATA Corporation)
99
STATA Corporation glm
Glm, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glm/product/STATA Corporation
Average 99 stars, based on 1 article reviews
glm - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
gsem command  (STATA Corporation)
99
STATA Corporation gsem command
Gsem Command, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gsem command/product/STATA Corporation
Average 99 stars, based on 1 article reviews
gsem command - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
proc glm command  (SAS institute)
90
SAS institute proc glm command
A Insulin sensitivity pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in insulin sensitivity in AZD4017+prednisolone and placebo+prednisolone groups. C Glucose disposal pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. D Change in glucose disposal in AZD4017+prednisolone and placebo+prednisolone groups. Data are medians and error bars are IQR. Data points represent individual patients. M/I value (Low insulin) AZD4017 + prednisolone n = 15, M/I value (Low insulin) placebo+prednisolone n = 15, Glucose disposal (Low insulin) AZD4017 + prednisolone n = 14, Glucose disposal (Low insulin) placebo+prednisolone n = 15. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo + prednisolone, red squares = post-treatment placebo + prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 2A, <t>generalised</t> <t>linear</t> <t>models</t> adjusting for baseline variability in each specified outcome; Fig. 2B and D and paired two-tailed t-test; Fig. 2C.
Proc Glm Command, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/proc glm command/product/SAS institute
Average 90 stars, based on 1 article reviews
proc glm command - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
version 7 0 7  (STATA Corporation)
99
STATA Corporation version 7 0 7
A Insulin sensitivity pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in insulin sensitivity in AZD4017+prednisolone and placebo+prednisolone groups. C Glucose disposal pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. D Change in glucose disposal in AZD4017+prednisolone and placebo+prednisolone groups. Data are medians and error bars are IQR. Data points represent individual patients. M/I value (Low insulin) AZD4017 + prednisolone n = 15, M/I value (Low insulin) placebo+prednisolone n = 15, Glucose disposal (Low insulin) AZD4017 + prednisolone n = 14, Glucose disposal (Low insulin) placebo+prednisolone n = 15. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo + prednisolone, red squares = post-treatment placebo + prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 2A, <t>generalised</t> <t>linear</t> <t>models</t> adjusting for baseline variability in each specified outcome; Fig. 2B and D and paired two-tailed t-test; Fig. 2C.
Version 7 0 7, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/version 7 0 7/product/STATA Corporation
Average 99 stars, based on 1 article reviews
version 7 0 7 - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

Image Search Results


A Insulin sensitivity pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in insulin sensitivity in AZD4017+prednisolone and placebo+prednisolone groups. C Glucose disposal pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. D Change in glucose disposal in AZD4017+prednisolone and placebo+prednisolone groups. Data are medians and error bars are IQR. Data points represent individual patients. M/I value (Low insulin) AZD4017 + prednisolone n = 15, M/I value (Low insulin) placebo+prednisolone n = 15, Glucose disposal (Low insulin) AZD4017 + prednisolone n = 14, Glucose disposal (Low insulin) placebo+prednisolone n = 15. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo + prednisolone, red squares = post-treatment placebo + prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 2A, generalised linear models adjusting for baseline variability in each specified outcome; Fig. 2B and D and paired two-tailed t-test; Fig. 2C.

Journal: Nature Communications

Article Title: 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

doi: 10.1038/s41467-023-36541-w

Figure Lengend Snippet: A Insulin sensitivity pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in insulin sensitivity in AZD4017+prednisolone and placebo+prednisolone groups. C Glucose disposal pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. D Change in glucose disposal in AZD4017+prednisolone and placebo+prednisolone groups. Data are medians and error bars are IQR. Data points represent individual patients. M/I value (Low insulin) AZD4017 + prednisolone n = 15, M/I value (Low insulin) placebo+prednisolone n = 15, Glucose disposal (Low insulin) AZD4017 + prednisolone n = 14, Glucose disposal (Low insulin) placebo+prednisolone n = 15. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo + prednisolone, red squares = post-treatment placebo + prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 2A, generalised linear models adjusting for baseline variability in each specified outcome; Fig. 2B and D and paired two-tailed t-test; Fig. 2C.

Article Snippet: College Station, TX: StataCorp LLC) and the PROC GLM command in SAS 9.4 for Windows (Copyright© 2013, SAS Institute Inc., Cary, NC, USA).

Techniques: Two Tailed Test

A Circulating TAG levels pre and post treatment in the AZD4017+prednisolone group. B Circulating TAG levels pre and post treatment in the placebo+prednisolone group. C Change in circulating TAG levels in AZD4017+prednisolone and placebo+prednisolone groups. D Circulating glycerol levels pre and post treatment in the AZD4017+prednisolone group. E Circulating glycerol levels pre and post treatment in the placebo+prednisolone group. F Change in circulating glycerol levels in AZD4017+prednisolone and placebo+prednisolone groups. G Adipose interstitial fluid glycerol levels pre and post treatment in the AZD4017+prednisolone group. H Adipose interstitial fluid glycerol levels pre and post treatment in the placebo+prednisolone group. I Change in adipose interstitial fluid glycerol levels in AZD4017+prednisolone and placebo+prednisolone groups. Subcutaneous adipose tissue interstitial fluid glycerol levels were increased by placebo + prednisolone treatment, but not when prednisolone was combined with AZD4017 ( G – I ). Data are medians, and error bars are IQR ( A – F , I ) and mean and SD ( G , H ). Data points represent individual patients ( A – F , I ) Circulating TAG AZD4017 + prednisolone: n = 15, Circulating TAG placebo + prednisolone: n = 15, Circulating Glycerol AZD4017 + prednisolone: n = 15, Circulating Glycerol placebo+prednisolone: Basal; n = 15, Low insulin; n = 15, High insulin; n = 14, Adipose interstitial fluid Glycerol AZD4017 + prednisolone: Basal; n = 12, Low insulin; n = 11, High insulin; n = 12, Adipose interstitial fluid Glycerol placebo + prednisolone: Basal; n = 13, Low insulin; n = 13, High insulin; n = 12, (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo+prednisolone, red squares = post-treatment placebo + prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 3A, generalised linear models adjusting for baseline variability in each specified outcome; Fig. 3 B, D and I and paired two-tailed t-test; Fig. 3C.

Journal: Nature Communications

Article Title: 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

doi: 10.1038/s41467-023-36541-w

Figure Lengend Snippet: A Circulating TAG levels pre and post treatment in the AZD4017+prednisolone group. B Circulating TAG levels pre and post treatment in the placebo+prednisolone group. C Change in circulating TAG levels in AZD4017+prednisolone and placebo+prednisolone groups. D Circulating glycerol levels pre and post treatment in the AZD4017+prednisolone group. E Circulating glycerol levels pre and post treatment in the placebo+prednisolone group. F Change in circulating glycerol levels in AZD4017+prednisolone and placebo+prednisolone groups. G Adipose interstitial fluid glycerol levels pre and post treatment in the AZD4017+prednisolone group. H Adipose interstitial fluid glycerol levels pre and post treatment in the placebo+prednisolone group. I Change in adipose interstitial fluid glycerol levels in AZD4017+prednisolone and placebo+prednisolone groups. Subcutaneous adipose tissue interstitial fluid glycerol levels were increased by placebo + prednisolone treatment, but not when prednisolone was combined with AZD4017 ( G – I ). Data are medians, and error bars are IQR ( A – F , I ) and mean and SD ( G , H ). Data points represent individual patients ( A – F , I ) Circulating TAG AZD4017 + prednisolone: n = 15, Circulating TAG placebo + prednisolone: n = 15, Circulating Glycerol AZD4017 + prednisolone: n = 15, Circulating Glycerol placebo+prednisolone: Basal; n = 15, Low insulin; n = 15, High insulin; n = 14, Adipose interstitial fluid Glycerol AZD4017 + prednisolone: Basal; n = 12, Low insulin; n = 11, High insulin; n = 12, Adipose interstitial fluid Glycerol placebo + prednisolone: Basal; n = 13, Low insulin; n = 13, High insulin; n = 12, (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo+prednisolone, red squares = post-treatment placebo + prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 3A, generalised linear models adjusting for baseline variability in each specified outcome; Fig. 3 B, D and I and paired two-tailed t-test; Fig. 3C.

Article Snippet: College Station, TX: StataCorp LLC) and the PROC GLM command in SAS 9.4 for Windows (Copyright© 2013, SAS Institute Inc., Cary, NC, USA).

Techniques: Two Tailed Test

A Night-time diastolic blood pressure pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in night-time diastolic blood pressure in AZD4017+prednisolone and placebo+prednisolone groups. Data are medians and error bars are IQR. Data points represent individual patients. AZD4017 + prednisolone; n = 13, placebo+prednisolone n = 14. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo+prednisolone, red squares = post-treatment placebo+prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 4A, generalised linear models adjusting for baseline variability in each specified outcome; Fig. 4B.

Journal: Nature Communications

Article Title: 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

doi: 10.1038/s41467-023-36541-w

Figure Lengend Snippet: A Night-time diastolic blood pressure pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in night-time diastolic blood pressure in AZD4017+prednisolone and placebo+prednisolone groups. Data are medians and error bars are IQR. Data points represent individual patients. AZD4017 + prednisolone; n = 13, placebo+prednisolone n = 14. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo+prednisolone, red squares = post-treatment placebo+prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 4A, generalised linear models adjusting for baseline variability in each specified outcome; Fig. 4B.

Article Snippet: College Station, TX: StataCorp LLC) and the PROC GLM command in SAS 9.4 for Windows (Copyright© 2013, SAS Institute Inc., Cary, NC, USA).

Techniques:

A Serum osteocalcin levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in serum osteocalcin levels in AZD4017+prednisolone and placebo+prednisolone groups. C Serum P1NP levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. D Change in serum P1NP levels in AZD4017+prednisolone and placebo+prednisolone groups. E Serum CTX levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. F Change in serum CTX levels in AZD4017+prednisolone and placebo+prednisolone groups. Data are medians and error bars are IQR. Data points represent individual patients. AZD4017 + prednisolone; n = 15, placebo+prednisolone n = 15. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo+prednisolone, red squares = post-treatment placebo+prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 5A, paired two-tailed t-test; Fig. 5C and E and generalised linear models adjusting for baseline variability in each specified outcome; Fig. 5B, D and F.

Journal: Nature Communications

Article Title: 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

doi: 10.1038/s41467-023-36541-w

Figure Lengend Snippet: A Serum osteocalcin levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in serum osteocalcin levels in AZD4017+prednisolone and placebo+prednisolone groups. C Serum P1NP levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. D Change in serum P1NP levels in AZD4017+prednisolone and placebo+prednisolone groups. E Serum CTX levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. F Change in serum CTX levels in AZD4017+prednisolone and placebo+prednisolone groups. Data are medians and error bars are IQR. Data points represent individual patients. AZD4017 + prednisolone; n = 15, placebo+prednisolone n = 15. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo+prednisolone, red squares = post-treatment placebo+prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 5A, paired two-tailed t-test; Fig. 5C and E and generalised linear models adjusting for baseline variability in each specified outcome; Fig. 5B, D and F.

Article Snippet: College Station, TX: StataCorp LLC) and the PROC GLM command in SAS 9.4 for Windows (Copyright© 2013, SAS Institute Inc., Cary, NC, USA).

Techniques: Two Tailed Test

A OX40 PHA levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in OX40 PHA levels in AZD4017+prednisolone and placebo+prednisolone groups. C OX40 VZV levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. D Change in OX40 VZV levels in AZD4017+prednisolone and placebo+prednisolone groups. Changes in glucocorticoid responsive circulating cytokines following treatment with placebo+prednisolone vs. AZD4017 + prednisolone ( E ). Data are medians and error bars are IQR. Data points represent individual patients. AZD4017 + prednisolone; n = 15, placebo+prednisolone n = 15. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo+prednisolone, red squares = post-treatment placebo+prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 6A and c, and generalised linear models adjusting for baseline variability in each specified outcome; Fig. 6B and D.

Journal: Nature Communications

Article Title: 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

doi: 10.1038/s41467-023-36541-w

Figure Lengend Snippet: A OX40 PHA levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. B Change in OX40 PHA levels in AZD4017+prednisolone and placebo+prednisolone groups. C OX40 VZV levels pre and post treatment in AZD4017+prednisolone and placebo+prednisolone groups. D Change in OX40 VZV levels in AZD4017+prednisolone and placebo+prednisolone groups. Changes in glucocorticoid responsive circulating cytokines following treatment with placebo+prednisolone vs. AZD4017 + prednisolone ( E ). Data are medians and error bars are IQR. Data points represent individual patients. AZD4017 + prednisolone; n = 15, placebo+prednisolone n = 15. (Light blue circles = pre-treatment AZD4017 + prednisolone, blue squares = post-treatment AZD4017 + prednisolone, pink circles = pre-treatment placebo+prednisolone, red squares = post-treatment placebo+prednisolone). Statistical tests: Wilcoxon signed-rank test; Fig. 6A and c, and generalised linear models adjusting for baseline variability in each specified outcome; Fig. 6B and D.

Article Snippet: College Station, TX: StataCorp LLC) and the PROC GLM command in SAS 9.4 for Windows (Copyright© 2013, SAS Institute Inc., Cary, NC, USA).

Techniques: